Ljubljana, Slovenia 2006/Background and Signalling Pathway

From 2006.igem.org

You do not have permission to edit this page, for the following reason:

You can view and copy the source of this page:

<center>[[Image:Logo-si1.gif|center|120 px]] <br> [[Image:line-si4.jpg]] <table cellpadding="10"> <tr><th>[[Ljubljana, Slovenia 2006|Home]]</th> <th>[[Ljubljana, Slovenia 2006/Project & Model|Project & Model]]</th> <th>[[Ljubljana, Slovenia 2006/Methods|Methods]]</th> <th>[[Ljubljana, Slovenia 2006/Results & Conclusions|Results & Conclusions]]</th> <th>[[Ljubljana, Slovenia 2006/Terms & References|Terms & References]]</th> <th>[[Ljubljana, Slovenia 2006/Team members|Team members]]</th></tr></table> [[Image:line-si3.jpg]] </center> <h1>Background</h1> [[Image:scheme2.jpg|right|thumb|360px|Figure 1: Toll-like receptors sense the presence of microbial infection and initiate the innate immune response.]] <p>When bacteria invade the human body, it has to respond quickly by activation of the innate branch of the immune system, which recognizes the broad spectrum of molecules, specific for pathogenic microorganisms. Immune response cells have on their surface a collection of receptors (Toll-like receptors - TLR), which recognize those "Pathogen associated molecular patterns" or [[Ljubljana, Slovenia 2006/Terms & References#Terms|PAMP]]s. [[Ljubljana, Slovenia 2006/Terms & References#Terms|PAMP]]s include various components of microorganisms (e.g. lipopolysaccharides, which are part of outer cell membrane of Gram-negative bacteria, flagellin, lipopeptides but also double-stranded RNA from viruses etc., which are each recognized by one of the 11 human TLRs) (Akira et al., 2004). This kind of cell signaling is the core of our efficient innate immune response (i.e. the fast-acting, not mediated by antibodies) against microbes. In some instances, however, extensive signaling mediated by TLR is not beneficial. If the cellular response gets out ouf control and becomes exaggerated, excessive inflammatory response may lead to sepsis, which can lead to severe organ failure and often the consequences are fatal (Cohen, 2002). Sepsis claims '''each year more than 150,000 casualties''' within the USA and a similar number within the EU. In the absence of an effective treatment of sepsis, the analysis of the signaling pathway may indicate the potential therapeutic targets. </p> <p>Response to bacterial stimulus is a double-edged sword - too strong response may lead to sepsis, while the too weak response does not overcome the bacterial infection, therefore both extremes have to be in the balance. '''The feedback mechanism that would limit the excessive cell stimulation, but would nevertheless maintain the responsiveness to bacterial infection could provide the path to an effective antiseptic strategy.'''</p> [[Image:balance.jpg|center|thumb|360px|Figure 2: Innate immune response has to maintain the delicate balance between the infection in case of low response and excessive inflammation in case of the exaggerated response.]] <h1>Signaling pathway of bacterial recognition in a nutshell</h1> <p>Toll-like receptors (TLRs) are the key gatekeepers of innate immunity, sensing and responding to invading microorganisms. So far in humans eleven different receptors are konwn that recognize specific molecular patterns which are specific for microbes, e.g. lipopolysaccharide ([[Ljubljana, Slovenia 2006/Terms & References#Terms|LPS]]), lipopeptides, double and single stranded RNA of viruses, nonmethylated [[Ljubljana, Slovenia 2006/Terms & References#Terms|CpG]] containing DNA, glycolipids, and several others.</p> <p>Most of the receptors and transducers in the signaling cascade involved in the initial stages of cell transduction have been identified, however the complete response is highly complex as for example [[Ljubljana, Slovenia 2006/Terms & References#Terms|LPS]] alone can affect transcription of more than 1000 different genes (Beutler, 2004).</p> <p>Binding of bacterial constituents ([[Ljubljana, Slovenia 2006/Terms & References#Terms|PAMP]]s) to TLR triggers the association of its intracellular TIR domains, which recruit from the cytoplasm to the membrane an adapter molecule [[Ljubljana, Slovenia 2006/Terms & References#Terms|MyD88]], which in turn transmits the signal to other components of the signaling cascade, particularly kinases, as shown in Figure 2. </p> [[Image:signalling1b.jpg|left|thumb|450px|Figure 3: TLR5 signaling pathway. The main step in the flagellin activation of TLR5 is the release of a transcription factor [[Ljubljana, Slovenia 2006/Terms & References#Terms|NF-&kappa;B]] and its translocation to the nucleus, where it is responsible for the activation of its target genes. Adapted from Liaudet et al. (2002) Drug News Perspect. 15, 1-13]] <p>When receptors sense the presence of microbial components, stimulation of TLRs occurs and triggers the association of MyD88 (myeloid differentiation primary-response protein 88), which in turn recruits IRAK4, thereby allowing its association with IRAK1. IRAK4 phosphorylates IRAK1 and with phosphorylated IRAK1 associates [[Ljubljana, Slovenia 2006/Terms & References#Terms|TRAF6]] (tumour necrosis factor receptor- associated factor 6). The complex of phosphorylated IRAK1 and [[Ljubljana, Slovenia 2006/Terms & References#Terms|TRAF6]] dissociates from the receptor and forms a complex with TAK1, TAB1 and TAB2, which induces the phosphorylation of TAB2 and TAK1. This leads to the ubiquitylation of [[Ljubljana, Slovenia 2006/Terms & References#Terms|TRAF6]], which induces the activation of TAK1. TAK1 phosphorylates IKK complex (inhibitor of nuclear factor &kappa;B (I&kappa;B)-kinase complex), which consists of IKK&alpha;, IKK&beta; and IKK&gamma;. The IKK complex then phosphorylates I&kappa;B, which is associated with [[Ljubljana, Slovenia 2006/Terms & References#Terms|NF-&kappa;B]] thus enabling its translocation to the nucleus. Phosphorylation of I&kappa;B leads to its ubiquitylation and subsequent degradation. This allows the important inflammatory transcription factor [[Ljubljana, Slovenia 2006/Terms & References#Terms|NF-&kappa;B]] to release and to translocate to the nucleus and to induce the transcription of a range of its target genes, such as cytokines and chemokines.</p> <p>Inflammatory cytokines, chemokines and interferons attract cells of the immune system (lymphocytes, macrophages) to the infected area. This is beneficial to organism, but if overactivated it can also lead to severe inflammation and sepsis (Cohen,2002; Beutler, 2004).</p> <center> [[Image:line-si4.jpg]] <table cellpadding="10"> <tr><th>[[Ljubljana, Slovenia 2006|Home]]</th> <th>[[Ljubljana, Slovenia 2006/Project & Model|Project & Model]]</th> <th>[[Ljubljana, Slovenia 2006/Methods|Methods]]</th> <th>[[Ljubljana, Slovenia 2006/Results & Conclusions|Results & Conclusions]]</th> <th>[[Ljubljana, Slovenia 2006/Terms & References|Terms & References]]</th> <th>[[Ljubljana, Slovenia 2006/Team members|Team members]]</th></tr></table> [[Image:line-si3.jpg]] </center>

Return to Ljubljana, Slovenia 2006/Background and Signalling Pathway.